Advertisement

Amino Acids

, Volume 50, Issue 9, pp 1177–1186 | Cite as

Carnosine and advanced glycation end products: a systematic review

  • Ramin Ghodsi
  • Sorayya Kheirouri
Review Article

Abstract

Advanced glycation end products (AGEs) are a cluster of heterogeneous molecules that are generated in a non-enzymatic reaction by the binding of sugars with amino groups of DNA, lipids and proteins. Carnosine is a naturally occurring dipeptide with antioxidant activity, which inhibits protein carbonylation and glycoxidation. This systematic review searched international sources for all published and unpublished original research in English from any year up to the end of April 2018. An electronic search of PubMed, Scopus and Google Scholar was conducted. 187 articles were initially found and 133 articles were selected after excluding duplicated data. Review articles, studies based on the components of carnosine and studies that were about the effects of carnosine on AGEs-induced changes were excluded. In total, 36 studies met the inclusion criteria. This included 19 in vitro studies, 15 animal studies and two human studies. All but two of the studies indicated that carnosine can prevent the formation of AGEs. The findings of this review indicating that carnosine has anti-glycating properties, and may hinder the formation of protein carbonyls and the cross-links induced by reduced sugars; however, there were few human studies. The mechanism by which carnosine prevents the formation of AGEs needs further investigation.

Keywords

Advanced glycation end products Carnosine Carbonyls Methylglyoxal Pentosidine Carboxymethyl lysine 

Notes

Author contributions

RG and SK conducted the search, and participated in manuscript writing. SK edited the manuscript. Both authors read and approved the final manuscript.

Funding

There is no source of financial support.

Compliance with ethical standards

Conflict of interest

The authors reported no conflict of interest.

Research involving human participants and/or animals

There were no human participants or animals.

Informed consent

Not applicable for this study.

References

  1. Abe H (2000) Role of histidine-related compounds as intracellular proton buffering constituents in vertebrate muscle. Biochemistry (Mosc) 65:757–765Google Scholar
  2. Aldini G, Orioli M, Rossoni G, Savi F, Braidotti P, Vistoli G, Yeum KJ, Negrisoli G, Carini M (2011) The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats. J Cell Mol Med 15:1339–1354CrossRefPubMedGoogle Scholar
  3. Alhamdani M-SS, Al-Azzawie HF, Abbas FK (2007a) Decreased formation of advanced glycation end-products in peritoneal fluid by carnosine and related peptides. Perit Dial Int 27(1):86–89PubMedGoogle Scholar
  4. Alhamdani MSS, Al-Kassir AHAM, Abbas FKH, Jaleel NA, Al-Taee MF (2007b) Antiglycation and antioxidant effect of carnosine against glucose degradation products in peritoneal mesothelial cells. Nephron Clin Pract 107:c26–c34CrossRefPubMedGoogle Scholar
  5. Alizadeh M, Kheirouri S (2017) Curcumin against advanced glycation end products (AGEs) and AGEs-induced detrimental agents. Crit Rev Food Sci Nutr 29:1–9.  https://doi.org/10.1080/10408398.2017.1396200 CrossRefGoogle Scholar
  6. Alsheblak MM, Elsherbiny NM, El-Karef A, El-Shishtawy MM (2016) Protective effects of l-carnosine on CCl4-induced hepatic injury in rats. Eur Cytokine Netw 27:6–15PubMedGoogle Scholar
  7. Ansurudeen I, Sunkari VG, Grünler J, Peters V, Schmitt CP, Catrina S-B, Brismar K, Forsberg EA (2012) Carnosine enhances diabetic wound healing in the db/db mouse model of type 2 diabetes. Amino Acids 43:127–134CrossRefPubMedGoogle Scholar
  8. Aydin F, Kalaz EB, Kucukgergin C, Coban J, Dogru-Abbasoglu S, Uysal M (2017) Carnosine treatment diminished oxidative stress and glycation products in serum and tissues of d-galactose-treated rats. Curr Aging Sci.  https://doi.org/10.2174/1871530317666170703123519 CrossRefGoogle Scholar
  9. Aydın AF, Bingül İ, Küçükgergin C, Doğan-Ekici I, Doğru Abbasoğlu S, Uysal M (2017a) Carnosine decreased oxidation and glycation products in serum and liver of high-fat diet and low-dose streptozotocin-induced diabetic rats. Int J Exp Pathol 98:278–288CrossRefPubMedPubMedCentralGoogle Scholar
  10. Aydın AF, Küçükgergin C, Bingül İ, Doğan-Ekici I, Doğru-Abbasoğlu S, Uysal M (2017b) Effect of carnosine on renal function, oxidation and glycation products in the kidneys of high-fat diet/streptozotocin-induced diabetic rats. Exp Clin Endocrinol Diabetes 125:282–289CrossRefGoogle Scholar
  11. Aydın A, Küçükgergin C, Çoban J, Doğan-Ekici I, Doğru-Abbasoğlu S, Uysal M, Koçak-Toker N (2018) Carnosine prevents testicular oxidative stress and advanced glycation end product formation in d-galactose-induced aged rats. Andrologia 50:e12939CrossRefGoogle Scholar
  12. Babizhayev MA (2012) Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine. Fundam Clin Pharmacol 26:86–117CrossRefPubMedGoogle Scholar
  13. Banerjee S, Sinha K, Chowdhury S, Sil PC (2018) Unfolding the mechanism of cisplatin induced pathophysiology in spleen and its amelioration by carnosine. Chem Biol Interact 279:159–170CrossRefPubMedGoogle Scholar
  14. Battah S, Ahmed N, Thornalley PJ (2002) Novel anti-glycation therapeutic agents: glyoxalase I mimetics. In: International congress series. Elsevier, Amsterdam, pp 107–111Google Scholar
  15. Bauer K (2005) Carnosine and homocarnosine, the forgotten, enigmatic peptides of the brain. Neurochem Res 30:1339–1345CrossRefPubMedGoogle Scholar
  16. Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Kloting I, Morcos M, Hofmann M, Tritschler H, Weigle B, Kasper M, Smith M, Perry G, Schmidt AM, Stern DM, Haring HU, Schleicher E, Nawroth PP (2001) Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50:2792–2808CrossRefPubMedGoogle Scholar
  17. Bingül İ, Yılmaz Z, Aydın AF, Çoban J, Doğru-Abbasoğlu S, Uysal M (2017) Antiglycation and anti-oxidant efficiency of carnosine in the plasma and liver of aged rats. Geriatr Gerontol Int 17:2610–2614CrossRefPubMedGoogle Scholar
  18. Boldyrev AA, Aldini G, Derave W (2013) Physiology and pathophysiology of carnosine. Physiol Rev 93:1803–1845CrossRefPubMedGoogle Scholar
  19. Brownson C, Hipkiss AR (2000) Carnosine reacts with a glycated protein. Free Radic Biol Med 28:1564–1570CrossRefPubMedGoogle Scholar
  20. Chen F, Wollmer MA, Hoerndli F, Münch G, Kuhla B, Rogaev EI, Tsolaki M, Papassotiropoulos A, Götz J (2004) Role for glyoxalase I in Alzheimer’s disease. Proc Natl Acad Sci USA 101:7687–7692CrossRefPubMedGoogle Scholar
  21. Choi HS, Lim J-Y, Chun HJ, Lee M, Kim ES, Keum B, Seo YS, Jeen Y-T, Um SH, Lee HS (2013) The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: comparison study with rebamipide. Life Sci 93:69–77CrossRefPubMedGoogle Scholar
  22. Coughlan MT, Thorburn DR, Penfold SA, Laskowski A, Harcourt BE, Sourris KC, Tan AL, Fukami K, Thallas-Bonke V, Nawroth PP (2009) RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J Am Soc Nephrol 20:742–752CrossRefPubMedPubMedCentralGoogle Scholar
  23. Delpierre G, Collard F, Fortpied J, Van Schaftingen E (2002) Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes. Biochem J 365:801–808CrossRefPubMedPubMedCentralGoogle Scholar
  24. Delpierrre G, Vertommen D, Communi D, Rider MH, Van Schaftingen E (2004) Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin. J Biol Chem 279:27613–27620CrossRefPubMedGoogle Scholar
  25. Fu M-X, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR (1996) The advanced glycation end product, N-(carboxymethyl) lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 271:9982–9986CrossRefPubMedGoogle Scholar
  26. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circul Res 107:1058–1070CrossRefGoogle Scholar
  27. Glomb MA, Monnier VM (1995) Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 270(17):10017–10026CrossRefPubMedGoogle Scholar
  28. Goossens V, Grooten J, De Vos K, Fiers W (1995) Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA 92:8115–8119CrossRefPubMedGoogle Scholar
  29. Gugliucci A, Smith M, Menini T (2002) Carnosine in physiological concentrations inhibits advanced glycation of histones by reactive trioses methylgyoxal and glyceraldehyde. Diabetes 51:A513Google Scholar
  30. Gugliucci A, Bastos DHM, Schulze J, Souza MFF (2009) Caffeic and chlorogenic acids in Ilex paraguariensis extracts are the main inhibitors of AGE generation by methylglyoxal in model proteins. Fitoterapia 80:339–344CrossRefPubMedGoogle Scholar
  31. Guney Y, Turkcu UO, Hicsonmez A, Andrieu MN, Guney HZ, Bilgihan A, Kurtman C (2006) Carnosine may reduce lung injury caused by radiation therapy. Med Hypotheses 66:957–959CrossRefPubMedGoogle Scholar
  32. Hipkiss AR (2009) Carnosine and its possible roles in nutrition and health. Adv Food Nutr Res 57:87–154CrossRefPubMedGoogle Scholar
  33. Hipkiss AR, Brownson C (2000) A possible new role for the anti-ageing peptide carnosine. Cell Mol Life Sci 57:747–753CrossRefPubMedGoogle Scholar
  34. Hipkiss AR, Chana H (1998) Carnosine protects proteins against methylglyoxal-mediated modifications. Biochem Biophys Res Commun 248:28–32CrossRefPubMedGoogle Scholar
  35. Hipkiss AR, Michaelis J, Syrris P (1995a) Non-enzymatic glycosylation of the dipeptide l-carnosine, a potential anti-protein-cross-linking agent. FEBS Lett 371:81–85CrossRefPubMedGoogle Scholar
  36. Hipkiss AR, Michaelis J, Syrris P, Dreimanis M (1995b) Strategies for the extension of human life span. In: Perspectives in human biology: genes, ethnicity and ageing. World Scientific, Singapore, pp 59–70Google Scholar
  37. Hipkiss A, Preston J, Himsworth D, Worthington V, Keown M, Michaelis J, Lawrence J, Mateen A, Allende L, Eagles P (1998a) Pluripotent protective effects of carnosine, a naturally occurring dipeptidea. Ann N Y Acad Sci 854:37–53CrossRefPubMedGoogle Scholar
  38. Hipkiss AR, Worthington VC, Himsworth DT, Herwig W (1998b) Protective effects of carnosine against protein modification mediated by malondialdehyde and hypochlorite. Biochim Biophys Acta 1380:46–54CrossRefPubMedGoogle Scholar
  39. Hipkiss AR, Brownson C, Carrier MJ (2001) Carnosine, the anti-ageing, anti-oxidant dipeptide, may react with protein carbonyl groups. Mech Ageing Dev 122:1431–1445CrossRefPubMedGoogle Scholar
  40. Hobart LJ, Seibel I, Yeargans GS, Seidler NW (2004) Anti-crosslinking properties of carnosine: significance of histidine. Life Sci 75:1379–1389CrossRefPubMedGoogle Scholar
  41. Horii Y, Shen J, Fujisaki Y, Yoshida K, Nagai K (2012) Effects of l-carnosine on splenic sympathetic nerve activity and tumor proliferation. Neurosci Lett 510:1–5CrossRefPubMedGoogle Scholar
  42. Houjeghani S, Kheirouri S, Faraji E, Jafarabadi MA (2018) l-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor–α levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial. Nutr Res 49:96–106CrossRefPubMedGoogle Scholar
  43. Ikeda T, Kimura K, Hama T, Tamaki N (1980) Activation of rabbit muscle fructose 1, 6-bisphosphatase by histidine and carnosine. J Biochem 87:179–185CrossRefPubMedGoogle Scholar
  44. Ito M, Shii D, Segami T, Kojima R, Suzuki Y (1992) Preventive actions of N-(3-aminopropionyl)-l-histidinato zinc (Z-103) through increases in the activities of oxygen-derived free radical scavenging enzymes in the gastric mucosa on ethanol-induced gastric mucosal damage in rats. Jpn J Pharmacol 59:267–274CrossRefPubMedGoogle Scholar
  45. Kheirouri S, Alizadeh M, Maleki V (2017) Zinc against advanced glycation end products. Clin Exp Pharmacol PhysiolGoogle Scholar
  46. Kim S-K, Kwon D, Kwon D-A, Paik IK, Auh J-H (2014) Optimizing carnosine containing extract preparation from chicken breast for anti-glycating agents. Korean J Food Sci An 34:127–132CrossRefGoogle Scholar
  47. Kumar H, Kim I-S, More SV, Kim B-W, Choi D-K (2014) Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases. Nat Prod Rep 31:109–139CrossRefPubMedGoogle Scholar
  48. Li N, Xia T, Nel AE (2008) The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles. Free Radic Biol Med 44:1689–1699CrossRefPubMedPubMedCentralGoogle Scholar
  49. Li JP, Gao Y, S-f Chu, Zhang Z, C-y Xia, Mou Z, X-y Song, W-b He, X-f Guo, N-h Chen (2014) Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol-and CCl 4-induced hepatic fibrosis. Acta Pharmacol Sin 35:1031CrossRefPubMedPubMedCentralGoogle Scholar
  50. Los M, Schenk H, Hexel K, Baeuerle PA, Dröge W, Schulze-Osthoff K (1995) IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J 14:3731–3740PubMedPubMedCentralCrossRefGoogle Scholar
  51. Macías-Cervantes MH, Rodríguez-Soto JMD, Uribarri J, Díaz-Cisneros FJ, Cai W, Garay-Sevilla ME (2015) Effect of an advanced glycation end product-restricted diet and exercise on metabolic parameters in adult overweight men. Nutrition 31:446–451CrossRefPubMedGoogle Scholar
  52. Mark AB, Poulsen MW, Andersen S, Andersen JM, Bak MJ, Ritz C, Holst JJ, Nielsen J, de Courten B, Dragsted LO (2014) Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women. Diabetes Care 37:88–95CrossRefPubMedGoogle Scholar
  53. Menini S, Iacobini C, Ricci C, Fantauzzi CB, Pugliese G (2015) Protection from diabetes-induced atherosclerosis and renal disease by d-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice. Diabetologia 58:845–853CrossRefPubMedGoogle Scholar
  54. Miller FP, Vandome AF, McBrewster J (2010) Glycolysis. Alphascript Publishing, Dortmund, GermanyGoogle Scholar
  55. Miyata T, Fu M-X, Kurokawa K, CvY De Strihou, Thorpe SR, Baynes JW (1998) Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? Kidney Int 54:1290–1295CrossRefPubMedGoogle Scholar
  56. Murata-Kamiya N, Kamiya H, Kaji H, Kasai H (2000) Mutations induced by glyoxal and methylglyoxal in mammalian cells. Nucleic Acids Symp Ser 44:3–4CrossRefGoogle Scholar
  57. Naghshvar F, Abianeh SM, Ahmadashrafi S, Hosseinimehr SJ (2012) Chemoprotective effects of carnosine against genotoxicity induced by cyclophosphamide in mice bone marrow cells. Cell Biochem Funct 30:569–573CrossRefPubMedGoogle Scholar
  58. Nakamura K, S-i Yamagishi, Adachi H, Kurita-Nakamura Y, Matsui T, Yoshida T, Imaizumi T (2007a) Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes. Mol Med 13:185CrossRefPubMedPubMedCentralGoogle Scholar
  59. Nakamura K, Si Yamagishi, Adachi H, Kurita-Nakamura Y, Matsui T, Yoshida T, Sato A, Imaizumi T (2007b) Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease. Diabetes Metab Res Rev 23:368–371CrossRefPubMedGoogle Scholar
  60. Nedić O, Rattan S, Grune T, Trougakos I (2013) Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology. Free Radic Res 47:28–38CrossRefPubMedGoogle Scholar
  61. Nelson D, Cox M (2000) Lehninger principle of biochemistry, vol 16, 3rd edn. Worth publisher, New York, pp 567–597Google Scholar
  62. Orioli M, Vistoli G, Regazzoni L, Pedretti A, Lapolla A, Rossoni G, Canevotti R, Gamberoni L, Previtali M, Carini M (2011) Design, synthesis, ADME properties, and pharmacological activities of β-alanyl-d-histidine (d-carnosine) prodrugs with improved bioavailability. ChemMedChem 6:1269–1282CrossRefPubMedGoogle Scholar
  63. Ozdogan K, Taskin E, Dursun N (2011) Protective effect of carnosine on adriamycin-induced oxidative heart damage in rats. Anadolu Kardiyol Derg 11:3–10CrossRefPubMedGoogle Scholar
  64. Pepper ED, Farrell MJ, Nord G, Finkel SE (2010) Antiglycation effects of carnosine and other compounds on the long-term survival of Escherichia coli. Appl Environ Microbiol 76:7925–7930CrossRefPubMedPubMedCentralGoogle Scholar
  65. Peters V, Riedl E, Braunagel M, Höger S, Hauske S, Pfister F, Zschocke J, Lanthaler B, Benck U, Hammes H-P (2014) Carnosine treatment in combination with ACE inhibition in diabetic rats. Regul Pept 194:36–40CrossRefPubMedGoogle Scholar
  66. Pfister F, Riedl E, Wang Q, vom Hagen F, Deinzer M, Harmsen MC, Molema G, Yard B, Feng Y, Hammes H-P (2011) Oral carnosine supplementation prevents vascular damage in experimental diabetic retinopathy. Cell Physiol Biochem 28:125–136CrossRefPubMedGoogle Scholar
  67. Pietkiewicz J, Bronowicka-Szydelko A, Dzierzba K, Danielewicz R, Gamian A (2011) Glycation of the muscle-specific enolase by reactive carbonyls: effect of temperature and the protection role of carnosine, pyridoxamine and phosphatidylserine. Protein J 30:149–158CrossRefPubMedGoogle Scholar
  68. Rashid I, van Reyk DM, Davies MJ (2007) Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro. FEBS Lett 581:1067–1070CrossRefPubMedGoogle Scholar
  69. Riedl E, Pfister F, Braunagel M, Brinkkötter P, Sternik P, Deinzer M, Bakker SJ, Henning RH, van den Born J, Krämer BK (2011) Carnosine prevents apoptosis of glomerular cells and podocyte loss in STZ diabetic rats. Cell Physiol Biochem 28:279–288CrossRefPubMedGoogle Scholar
  70. Rubtsov A, Schara M, Sentjurc M, Boldyrev A (1991) Hydroxyl radical-scavenging activity of carnosine: a spin trapping study. Acta Pharm Jugosl 41:401–407Google Scholar
  71. Sakiyama H, Takahashi M, Yamamoto T, Teshima T, Lee SH, Miyamoto Y, Misonou Y, Taniguchi N (2006) The internalization and metabolism of 3-deoxyglucosone in human umbilical vein endothelial cells. J Biochem 139:245–253CrossRefPubMedGoogle Scholar
  72. Sale C, Artioli GG, Gualano B, Saunders B, Hobson RM, Harris RC (2013) Carnosine: from exercise performance to health. Amino Acids 44:1477–1491CrossRefPubMedGoogle Scholar
  73. Sauer T, Raithel M, Kressel J, Münch G, Pischetsrieder M (2013) Activation of the transcription factor Nrf2 in macrophages, Caco-2 cells and intact human gut tissue by Maillard reaction products and coffee. Amino Acids 44:1427–1439CrossRefPubMedGoogle Scholar
  74. Schalkwijk CG, Miyata T (2012) Early-and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics. Amino Acids 42:1193–1204CrossRefPubMedGoogle Scholar
  75. Schulze-Osthoff K, Bakker A, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W (1992) Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 267:5317–5323PubMedGoogle Scholar
  76. Seidler NW, Yeargans GS, Morgan TG (2004) Carnosine disaggregates glycated α-crystallin: an in vitro study. Arch Biochem Biophys 427:110–115CrossRefPubMedGoogle Scholar
  77. Shi Q, Abusarah J, Zaouter C, Moldovan F, Fernandes JC, Fahmi H, Benderdour M (2014) New evidence implicating 4-hydroxynonenal in the pathogenesis of osteoarthritis in vivo. Arthritis Rheumatol 66:2461–2471CrossRefPubMedGoogle Scholar
  78. Shin D-S, Kim KW, Chung HY, Yoon S, Moon J-O (2013) Effect of sinapic acid against carbon tetrachloride-induced acute hepatic injury in rats. Arch Pharmacal Res 36:626–633CrossRefGoogle Scholar
  79. Smit AJ, Lutgers H (2004) The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation. Curr Med Chem 11:2767–2784CrossRefPubMedGoogle Scholar
  80. Stegen S, Stegen B, Aldini G, Altomare A, Cannizzaro L, Orioli M, Gerlo S, Deldicque L, Ramaekers M, Hespel P (2015) Plasma carnosine, but not muscle carnosine, attenuates high-fat diet-induced metabolic stress. Appl Physiol Nutr Metab 40:868–876CrossRefPubMedGoogle Scholar
  81. Teufel M, Saudek V, Ledig J-P, Bernhardt A, Boularand S, Carreau A, Cairns NJ, Carter C, Cowley DJ, Duverger D (2003) Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. J Biol Chem 278:6521–6531CrossRefPubMedGoogle Scholar
  82. Torreggiani A, Bonora S, Fini G (2000a) Raman and IR spectroscopic investigation of zinc (II)–carnosine complexes. Biopolymers 57:352–364CrossRefPubMedGoogle Scholar
  83. Torreggiani A, Tamba M, Fini G (2000b) Binding of copper (II) to carnosine: Raman and IR spectroscopic study. Biopolymers 57:149–159CrossRefPubMedGoogle Scholar
  84. Ukeda H, Hasegawa Y, Harada Y, Sawamura M (2002) Effect of carnosine and related compounds on the inactivation of human Cu, Zn-superoxide dismutase by modification of fructose and glycolaldehyde. Biosci Biotechnol Biochem 66:36–43CrossRefPubMedGoogle Scholar
  85. Uribarri J, Cai W, Ramdas M, Goodman S, Pyzik R, Chen X, Zhu L, Striker GE, Vlassara H (2011) Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes. Diabetes Care 34:1610–1616CrossRefPubMedPubMedCentralGoogle Scholar
  86. Valko M, Morris H, Cronin M (2005) Metals, toxicity and oxidative stress. Curr Med Chem 12:1161–1208CrossRefPubMedGoogle Scholar
  87. Vinson JA, Howard TB (1996) Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J Nutr Biochem 7:659–663CrossRefGoogle Scholar
  88. Vistoli G, Straniero V, Pedretti A, Fumagalli L, Bolchi C, Pallavicini M, Valoti E, Testa B (2012) Predicting the physicochemical profile of diastereoisomeric histidine-containing dipeptides by property space analysis. Chirality 24:566–576CrossRefPubMedGoogle Scholar
  89. Vistoli G, Colzani M, Mazzolari A, Gilardoni E, Rivaletto C, Carini M, Aldini G (2017) Quenching activity of carnosine derivatives towards reactive carbonyl species: focus on α-(methylglyoxal) and β-(malondialdehyde) dicarbonyls. Biochem Biophys Res Commun 492:487–492CrossRefPubMedGoogle Scholar
  90. Wang P, Zhang Z, Ma X, Huang Y, Liu X, Tu P, Tong T (2003) HDTIC-1 and HDTIC-2, two compounds extracted from Astragali Radix, delay replicative senescence of human diploid fibroblasts. Mech Ageing Dev 124:1025–1034CrossRefPubMedGoogle Scholar
  91. Weigand T, Singler B, Fleming T, Nawroth P, Klika KD, Thiel C, Baelde H, Garbade SF, Wagner AH, Hecker M (2018) Carnosine catalyzes the formation of the oligo/polymeric products of methylglyoxal. Cell Physiol Biochem 46:713–726CrossRefPubMedGoogle Scholar
  92. Wu H-C, Shiau C-Y, Chen H-M, Chiou T-K (2003) Antioxidant activities of carnosine, anserine, some free amino acids and their combination. J Food Drug Anal 11:148–153Google Scholar
  93. Yao D, Brownlee M (2010) Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes 59:249–255CrossRefPubMedGoogle Scholar
  94. Yeargans GS, Seidler NW (2003) Carnosine promotes the heat denaturation of glycated protein. Biochem Biophys Res Commun 300:75–80CrossRefPubMedGoogle Scholar
  95. Yılmaz Z, Kalaz EB, Aydın AF, Soluk-Tekkeşin M, Doğru-Abbasoğlu S, Uysal M, Koçak-Toker N (2017) The effect of carnosine on methylglyoxal-induced oxidative stress in rats. Arch Physiol Biochem 123:192–198CrossRefPubMedGoogle Scholar
  96. Yoshikawa T, Naito Y, Tanigawa T, Yoneta T, Kondo M (1991) The antioxidant properties of a novel zinc-carnosine chelate compound, N-(3-aminopropionyl)–histidinato zinc. Biochim Biophys Acta 1115:15–22CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Nutrition, Faculty of NutritionTabriz University of Medical SciencesTabrizIran

Personalised recommendations